Back
Soleno Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
60
SLNO
Soleno Therapeutics
Last Price:
47.19
Seasonality Move:
42.76%
Sell
32
ALNY
Alnylam Pharmaceuticals
Last Price:
254.21
Seasonality Move:
4.15%
Buy
60
Soleno Therapeutics (SLNO)
is a Buy
Is Soleno Therapeutics a Buy, Sell or Hold?
- The current Soleno Therapeutics [SLNO] share price is $47.35. The Score for SLNO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- SLNO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $253.91. The Score for ALNY is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SLNO Stock Price Chart
What is Soleno Therapeutics's stock price today?
-
The Soleno Therapeutics share price today is $47.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLNO is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $253.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.
SLNO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.57 | Sell |
| Relative Strength Index (14 RSI): | 33.77 | Sell |
| Chaikin Money Flow: | -200556 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.41 - 57.29) | Sell |
| Bollinger Bands (100): | (47.52 - 54.64) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.67 | Sell |
| Relative Strength Index (14 RSI): | 45.91 | Sell |
| Chaikin Money Flow: | -30240 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (243.42 - 267.8) | Sell |
| Bollinger Bands (100): | (249.2 - 281.58) | Sell |
SLNO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.83 | Sell |
| 20-day SMA: | 52.98 | Sell |
| 50-day SMA: | 53.46 | Sell |
| 200-day SMA: | 47.2 | Buy |
| 8-day EMA: | 49.94 | Sell |
| 20-day EMA: | 52.14 | Sell |
| 50-day EMA: | 52.61 | Sell |
| 200-day EMA: | 46.25 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 253.81 | Buy |
| 20-day SMA: | 251.12 | Buy |
| 50-day SMA: | 268.29 | Sell |
| 200-day SMA: | 216.8 | Buy |
| 8-day EMA: | 253.79 | Buy |
| 20-day EMA: | 255.64 | Sell |
| 50-day EMA: | 261.14 | Sell |
| 200-day EMA: | 233.37 | Buy |
Soleno Therapeutics Earnings Growth & SLNO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.45 per share, and an increase next year of $0.71 per share.
Soleno Therapeutics Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||